RxDoctor Payments DataLook up a doctor →

Ronald Poblete, MD

Infectious Disease · Saddle Brook, NJNPI 1740271998

Payments from drug & device makers

$250,237in general payments, 2019–2025

Across 882 payments — averaging $283.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Molecular Systems, Inc.$128K
  • Viiv Healthcare Company$70K
  • GSK$36K
  • Gilead$8K
  • Abbott$3K
  • Theratechnologies Inc.$1K
  • plus $3K from 12 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$250,237 in reported general payments places this provider in the 95th percentile of 334 infectious disease providers in New Jersey.

See all infectious disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$186,518
Medicare patients
205
Services billed
2,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Saddle Brook

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →